The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond
Open accessAbstract
Tryptase is a serine protease that is predominantly produced by tissue mast cells (MCs) and stored in secretory granules together with other pre-formed mediators. MC activation, degranulation and mediator release contribute to various immunological processes, but also to several specific diseases, such as IgE-dependent allergies and clonal MC disorders. Biologically active tryptase tetramers primarily derive from the two genes TPSB2 (encoding β-tryptase) and TPSAB1 (encoding either α- or β-tryptase). Based on the most common gene copy numbers, three genotypes, 0α:4β, 1α:3β and 2α:2β, were defined as “canonical”. About 4–6% of the general population carry germline TPSAB1-α copy number gains (2α:3β, 3α:2β or more α-extra-copies), resulting in elevated basal serum tryptase levels. This condition has recently been termed hereditary alpha tryptasemia (HαT). Although many carriers of HαT appear to be asymptomatic, a number of more or less specific symptoms have been associated with HαT. Recent studies have revealed a significantly higher HαT prevalence in patients with systemic mastocytosis (SM) and an association with concomitant severe Hymenoptera venom-induced anaphylaxis. Moreover, HαT seems to be more common in idiopathic anaphylaxis and MC activation syndromes (MCAS). Therefore, TPSAB1 genotyping should be included in the diagnostic algorithm in patients with symptomatic SM, severe anaphylaxis or MCAS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, only α- and β-tryptase are clinically relevant and are the most abundant [7].”
From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“heterotetramers have been shown to cleave a subunit of the epidermal growth factor-like module-containing mucin-like hormone receptor-like 2 (EMR2) in vivo thus causing a decrease in the threshold for vibration-induced MC degranulation (16).”
From Defining “Normal” basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis (2025) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IgE and mast cells in allergic disease
Galli, S. J., & Tsai, M. (2012) · Nature Medicine · doi:10.1038/nm.2755 · Cited by 1,799
Metcalfe, D. D., Baram, D., & Mekori, Y. A. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1033 · Cited by 1,723
World Allergy Organization Anaphylaxis Guidance 2020
Cardona, V., Ansotegui, I. J., Ebisawa, M., El‐Gamal, Y., Fernández‐Rivas, M., Fìneman, S. M., Geller, M., Gonzalez‐Estrada, A., Greenberger, P. A., Borges, M. S., et al. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2020.100472 · Cited by 1,272
Prognostic discrimination in "good-risk" chronic granulocytic leukemia
Sokal, J., Cox, E. B., Baccarani, M., Tura, S., Gomez, G., Je, R., Tso, C. Y., Braun, T., Clarkson, B., & Cervantes, F. (1984) · Blood · doi:10.1182/blood.v63.4.789.bloodjournal634789 · Cited by 1,208
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Núñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,114
Self-citationGalli, S. J., Borregaard, N., & Wynn, T. A. (2011) · Nature Immunology · doi:10.1038/ni.2109 · Cited by 1,055
Two types of human mast cells that have distinct neutral protease compositions.
Irani, A.-M. A., Schechter, N. M., Craig, S. S., DeBlois, G., & Schwartz, L. B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4464 · Cited by 1,007
New Concepts about the Mast Cell
Flier, J. S., Underhill, L. H., & Galli, S. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301283280408 · Cited by 981
Nagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S. H., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 871
Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation
Kitamura, Y., Go, S.-R., & Hatanaka, K. (1978) · Blood · doi:10.1182/blood.v52.2.447.bloodjournal522447 · Cited by 830
Cited by
Sorted by citations
Valent, P., Hartmann, K., Bonadonna, P., Gülen, T., Brockow, K., Alvarez-Twose, I., Hermine, O., Niedoszytko, M., Carter, M. C., Hoermann, G., et al. (2022) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.05.007 · Cited by 90
Self-citationHu, X., Qi, C., Feng, F., Wang, Y., Di, T., Meng, Y., Wang, Y., Zhao, N., Zhang, X., Li, P., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154384 · Cited by 75
Mast cell activation syndromes: Collegium Internationale Allergologicum update 2022
Valent, P., Hartmann, K., Bonadonna, P., Niedoszytko, M., Triggiani, M., Arock, M., & Brockow, K. (2022) · International Archives of Allergy and Immunology · doi:10.1159/000524532 · Cited by 55
Self-citationMastocytosis and Mast Cell Activation Disorders: Clearing the Air
Jackson, C. W., Pratt, C. M., Rupprecht, C. P., Pattanaik, D., & Krishnaswamy, G. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011270 · Cited by 55
Selected recent advances in understanding the role of human mast cells in health and disease
Levi‐Schaffer, F., Gibbs, B. F., Hallgren, J., Pucillo, C. E. M., Redegeld, F. A., Siebenhaar, F., Vitte, J., Mezouar, S., Michel, M., Puzzovio, P. G., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.030 · Cited by 55
Metadata
- Authors
- Sprinzl, B., Greiner, G., Uyanik, G., Arock, M., Haferlach, T., Sperr, W. R., Valent, P., & Hoermann, G.
- Affiliations
- Hanusch Hospital (AT)
- Ludwig Boltzmann Institute for Hematology and Oncology (AT)
- Sigmund Freud Privatuniversität Wien (AT)
- Inserm (FR)
- Munich Leukemia Laboratory (Germany) (DE)
- Corresponding author
- Hoermann, Gregor
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-02-28
- Volume
- 22
- Issue
- 5
- Pages
- 2458
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7957558
- OpenAlex
- W3133988438
- Cited by
- 51
- References
- 207
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 7 · 2022: 13 · 2021: 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Austrian Science Fund (P26079-B13, P32470-684 B, F4701-B20, F4704-B20)
- Medical-Scientific Fund of the Mayor of Vienna (19019)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- tryptase, hereditary alpha-tryptasemia, TPSAB1, mast cells, systemic mastocytosis, idiopathic anaphylaxis, mast cell activation syndrome, gene copy number, genetic control, serum tryptase
- MeSH terms
- Animals, Humans, Mast Cells, Mastocytosis, Gene Expression Regulation, Enzymologic, Genetic Diseases, Inborn, Tryptases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
